
“Our founding principle was simple: every researcher and manufacturer deserves access to peptides of the highest purity, delivered with scientific transparency and commercial reliability.”
Dr. James ChenCo-Founder & Chief Scientific Officer
A vertically integrated GMP manufacturer trusted by pharmaceutical, biotech, and cosmetic companies across 50+ countries — delivering precision, purity, and partnership.
From a small Hong Kong lab to a globally recognized GMP manufacturer — our journey has been defined by scientific rigor, client trust, and relentless innovation.

“Our founding principle was simple: every researcher and manufacturer deserves access to peptides of the highest purity, delivered with scientific transparency and commercial reliability.”
Dr. James ChenCo-Founder & Chief Scientific OfficerPEPLYRA was established by a team of MIT and Harvard biochemists with a mission to make high-purity peptides accessible to researchers worldwide.
Achieved ISO 9001 and GMP certification for our first dedicated synthesis suite, enabling supply to regulated pharmaceutical clients.
Registered with the U.S. FDA as an API manufacturer and began exporting to Europe, Japan, and Australia. Client base grew to 300+ companies.
Opened our state-of-the-art manufacturing campus with 8 dedicated synthesis suites, analytical labs, and a cold-chain logistics center.
Launched full-service OEM and private label programs, enabling brands to bring peptide-based products to market under their own identity.
Achieved ICH Q7 compliance for API manufacturing and expanded distribution to 50+ countries, serving 1,200+ pharmaceutical and biotech clients.
Launched our proprietary continuous-flow synthesis platform, reducing lead times by 40% and enabling production of complex long-chain peptides at commercial scale.
Our quality systems meet the strictest international standards, giving partners confidence from research through commercial supply.
Our QMS covers the full lifecycle from raw material sourcing through final product release, ensuring consistent quality across all batches.
≥98% purity guaranteed by RP-HPLC
ESI-MS and MALDI-TOF confirmation
Full composition verification
LAL method, <1 EU/mg
Chiral purity confirmation
Certificate of Analysis with every batch
Our Hong Kong campus brings synthesis, analysis, formulation, and global cold-chain logistics together under one quality system.

8 dedicated GMP synthesis suites with automated SPPS reactors, capable of producing from 1mg to 10kg per batch.
Our leadership team combines deep scientific expertise, manufacturing discipline, and global commercial experience.
20+ years in peptide chemistry and drug discovery. Former Principal Scientist at Pfizer. Author of 60+ peer-reviewed publications on solid-phase peptide synthesis and GLP-1 analogs.
15 years leading global pharmaceutical operations. Previously VP of Business Development at Lonza. Expert in scaling GMP manufacturing and building international distribution networks.
18 years in pharmaceutical QA/QC and regulatory submissions. Led FDA and EMA inspection readiness programs for 3 major API manufacturers. Expert in ICH Q7 and EU GMP Annex 11.
12 years specializing in continuous-flow synthesis and scale-up chemistry. Developed proprietary synthesis protocols for 15+ commercial peptide APIs. Expert in complex long-chain peptide manufacturing.
10 years building pharmaceutical supply chain partnerships across North America, Europe, and Asia-Pacific. Manages relationships with 200+ key accounts including top-20 pharma companies.
14 years in pharmaceutical formulation development and lyophilization. Expert in peptide stability, excipient selection, and sterile fill-finish operations for injectable and topical dosage forms.

Whether you need catalog peptides, custom synthesis, or full OEM support, our team is ready to help move your program forward.